Pliant Therapeutics (PLRX) Amortizatization of Intangibles (2021 - 2026)
Pliant Therapeutics (PLRX) reported Amortizatization of Intangibles of $835000.0 for Q1 2026, up 2.71% year-over-year from $813000.0 in Q1 2025, and up 0.85% quarter-over-quarter from $828000.0 in Q4 2025.
Pliant Therapeutics (PLRX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 6 years of Amortizatization of Intangibles data on file, last reported at $835000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $835000.0, up 2.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 7.93% YoY), and the FY2025 annual result was $3.3 million, down 5.04% from the prior year.
- Amortizatization of Intangibles climbed to $835000.0 in Q1 2026 per PLRX's latest filing, from $828000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $3.9 million in Q2 2023 and troughed at -$7.8 million in Q4 2023.
- A 5-year average of $694764.7 and a median of $815000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles plunged 838.71% in 2022, then surged 959.02% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.6 million in 2022, then plunged by 590.9% to -$7.8 million in 2023, then surged by 110.36% to $811000.0 in 2024, then advanced by 2.1% to $828000.0 in 2025, then rose by 0.85% to $835000.0 in 2026.
- Business Quant data shows PLRX's Amortizatization of Intangibles at $835000.0 in Q1 2026, $828000.0 in Q4 2025, and $821000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Pliant Therapeutics | 71.38 Mn | 71.38 Mn | - | 835,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 835,000.00 |
| Mar 31, 2026 | 835,000.00 |
| Dec 31, 2025 | 828,000.00 |
| Dec 31, 2025 | 828,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Mar 31, 2025 | 813,000.00 |
| Mar 31, 2025 | 813,000.00 |
| Dec 31, 2024 | 811,000.00 |
| Dec 31, 2024 | 811,000.00 |
| Sep 30, 2024 | 809,000.00 |
| Sep 30, 2024 | 809,000.00 |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 681,000.00 |
| Mar 31, 2024 | 681,000.00 |
| Dec 31, 2023 | -7.83 Mn |
| Dec 31, 2023 | -7.83 Mn |